Effects of cloprostenol sodium at final prostaglandin F2α of Ovsynch on complete luteolysis and pregnancy per artificial insemination in lactating dairy cows

Luteolysis is a key event in Ovsynch programs of lactating dairy cows. Studies indicate that as many as 20% of cows treated with a Presynch/Ovsynch program have delayed or incomplete luteolysis using dinoprost tromethamine. Cows must have complete luteolysis to have a chance to become pregnant. Dinoprost tromethamine has a short half-life of approximately 7 to 8 min. Cloprostenol sodium is more resistant to endogenous metabolism and is maintained in circulation for a longer time (half-life = 3 h). The objective was to determine if cloprostenol sodium could increase the percentage of cows with complete luteolysis and subsequent pregnancy per artificial insemination (P/AI) in lactating dairy cows compared with dinoprost tromethamine when administered within a presynchronization plus Ovsynch program for first artificial insemination (n = 652) and an Ovsynch resynchronization program for second or later AI (second+; n = 394). Blood samples were collected daily for 5 d beginning at the PGF_2α of Ovsynch in a subset of cows (n = 680) for first and second+ AI to measure circulating concentrations of progesterone (P₄) and estradiol (E₂). Complete luteolysis was defined as cows with functional corpus luteum (CL) at time of treatment and serum concentrations of P₄ <0.5 ng/mL at 56, 72, and 96 h after treatment. Percentage of cows with functional CL that had complete luteolysis after treatment was not greater for cloprostenol sodium compared with dinoprost tromethamine in first (79 vs. 80%, respectively) or second+ AI (70 vs. 72%, respectively). In addition, mean serum concentrations of P₄ were not less for cows treated with cloprostenol sodium following treatment. Pregnancy per AI of cows treated with cloprostenol sodium tended to be greater than dinoprost tromethamine for first (40 vs. 35%; respectively) but not second+ AI (23 vs. 21%, respectively). Cows with greater serum P₄ concentrations at time of PGF_2α of Ovsynch had a greater probability of undergoing complete luteolysis after PGF_2α of Ovsynch and pregnancy at 39 d after timed AI (i.e., 50% pregnant at 8 vs. 28% pregnant at 4 ng/mL P₄). Serum concentrations of E₂ at 56 h after PGF_2α of Ovsynch were a positive predictor of pregnancy at 39 d after timed AI. In summary, cloprostenol sodium tended to improve P/AI. Cows with greater serum concentrations of P₄ at time of PGF_2α of Ovsynch had a greater chance of luteolysis and pregnancy.     

Hormonal manipulations in the 5-day timed artificial insemination protocol to optimize estrous cycle synchrony and fertility in dairy heifers

Objectives were to determine the effects of GnRH at the initiation of the 5-d timed artificial insemination (AI) program combined with 2 injections of PGF_2α on ovarian responses and pregnancy per AI (P/AI) in dairy heifers, and the role of progesterone concentrations on LH release and ovulation in response to GnRH. In study 1, heifers received a controlled internal drug release (CIDR) insert containing 1.38 g of progesterone on d 0, an injection of 25 mg of PGF_2α and CIDR removal on d 5, and an injection of 100 μg GnRH concurrently with AI on d 8. Heifers were assigned to receive no additional treatment (control; n = 559) or an injection of GnRH on d 0 and a second injection of PGF_2α on d 6 (G2P; n = 547). In study 2, all heifers were treated as described for the control in study 1, and were allocated to receive no additional treatment (control; n = 723), an injection of PGF_2α on d 6 (NG2P; n = 703), or an injection of GnRH on d 0 and an injection of PGF_2α on d 6 (G2P; n = 718). In study 3, heifers received a CIDR on d 7 after ovulation and were assigned randomly to a low-progesterone (LP; n = 6) treatment in which 2 injections of 25 mg of PGF_2α each were administered 12 h apart, on d 7 and 7.5 after ovulation, or to a high-progesterone (HP; n = 12) treatment in which no PGF_2α was administered. On d 8, heifers received 100 μg of GnRH and blood was sampled at every 15 min from −30 to 180 min relative to the GnRH for assessment of LH concentrations. Additionally, 94 heifers were assigned to LP or HP and ovulation in response to GnRH was evaluated. In study 1, P/AI was greater for G2P than for the control on d 32 (59.4 vs. 53.5%) and 60 after AI (56.6 vs. 51.3%). In study 2, administration of GnRH on d 0 increased the proportion of heifers with a new corpus luteum on d 5 (control = 21.9 vs. NG2P = 20.1 vs. G2P = 34.4%). Administration of a second PGF_2α increased the proportion of heifers with progesterone <0.5 ng/mL at AI (control = 83.1 vs. NG2P = 93.0 and G2P = 87.2%). Pregnancy per AI was greater for G2P than for control and NG2P on d 32 (control = 52.9 vs. NG2P = 55.0 vs. G2P = 61.7%) and 60 (control = 49.0 vs. NG2P = 51.6 vs. G2P = 59.1%). In study 3, HP attenuated LH release and reduced ovulation (19.0 vs. 48.4%) in response to GnRH compared with LP. Combining GnRH and 2 doses of PGF_2α in the 5-d timed AI protocol improved follicle turnover, luteolysis, and P/AI in heifers. Elevated concentrations of progesterone suppressed LH release and are linked with the low ovulatory response to the initial GnRH treatment of the protocol.     

Effects of altering the ratio of dietary n-6 to n-3 fatty acids on spontaneous luteolysis in lactating dairy cows

Objectives were to evaluate the effects of altering the dietary ratio of omega-6 (n-6) to omega-3 (n-3) fatty acids on the profile of fatty acids and expression of genes related to the prostaglandin biosynthesis on endometrial tissue, uterine secretion of PGF_2α, and timing of spontaneous luteolysis in dairy cows. Multiparous lactating Holstein cows (n = 45) were blocked based on milk yield and, within each block, assigned randomly to 1 of 3 dietary treatments at 14 d postpartum for 90 d. Diets were supplemented with a mixture of Ca salts of fish, safflower, and palm oils to create 3 different ratios of n-6 to n-3 fatty acids, namely R4, R5, and R6, which resulted in 3.9, 4.9, and 5.9 parts of n-6 to 1 part of n-3 fatty acids, respectively. Blood was sampled every 2 h from d 16 to 23 of the estrous cycle and assayed for concentrations of progesterone and the PGF_2α metabolite 13,14-dihydro-15-keto-PGF_2α (PGFM). In a subsequent estrous cycle, endometrial tissue was collected for biopsy on d 8 and endometrial fatty acids profile and gene expression were quantified. The proportion of arachidonic acid of the endometrial fatty acids increased as the dietary ratio n-6 to n-3 fatty acids increased (R4 = 9.05, R5 = 11.64, and R6 = 13.41%). On the other hand, proportions of eicosapentaenoic (R4 = 2.85, R5 = 2.14, and R6 = 2.02%) and docosahexaenoic (R4 = 3.30, R5 = 1.57, and R6 = 1.08%) decreased as the ratio of n-6 to n-3 fatty acids in the diet increased. Increasing the ratio of dietary n-6 to n-3 fatty acids increased mRNA expression of estrogen receptor 1, oxytocin receptor, cyclooxygenase 2, prostaglandin E and F synthases, and steroidogenic acute regulatory protein in endometrium, but decreased expression of peroxisome proliferator-activated receptor gamma and insulin-like growth factor-1. The changes in endometrium gene expression caused by dietary treatments were associated with changes in the ratio of n-6 to n-3 fatty acids in the endometrium. As the ratio increased from R4 to R6, the number of PGFM pulses (R4 = 5.6, R5 = 4.3, and R6 = 3.8 ± 0.6 pulses; least squares means ± standard error of the means) decreased, but the amplitude of the greatest PGFM pulse increased (R4 = 226, R5 = 267, and R6 = 369 ± 38 pg/mL). Luteolysis by d 23 of the estrous cycle was observed in 79.6% of the cows (R4 = 11/14; R5 = 13/15; and R6 = 11/15) and day of spontaneous luteolysis did not differ among treatments (R4 = 20.8; R5 = 21.1; and R6 = 21.0 ± 0.4). Three pulses of PGFM was the best predictor of luteolysis in dairy cows. Collectively, supplying the same quantity of fatty acids in the diet of lactating dairy cows, but altering the ratio of n-6 to n-3 fatty acids, influenced the endometrial fatty acids profile and gene expression and altered the pattern of prostaglandin synthesis; however, the changes were not sufficient to alter the length of the estrous cycle.     

Dose frequency of prostaglandin F2α administration to dairy cows exposed to presynchronization and either 5- or 7-day Ovsynch program durations: Ovulatory and luteolytic risks

We hypothesized (1) that neither duration of the Ovsynch program nor dose frequency of PGF_2α would change the proportion of cows with complete luteolysis (progesterone <0.4 ng/mL 72 h after PGF_2α) and (2) that the additional GnRH treatment administered as part of a presynchronization program would not alter the proportion of anovulatory cows starting the timed artificial insemination (AI) program compared with an alternative shorter presynch program including only 1 GnRH treatment. Lactating Holstein cows (n = 406) were milked 3 times daily and enrolled in a 2 × 2 × 2 factorial experiment consisting of 8 treatments before the first postpartum AI. Treatments were used to test ovulatory, luteal, and luteolytic outcomes to 3 main effects: (1) 2 GnRH-PGF_2α presynchronization programs (PG-3-G vs. Double Ovsynch), (2) 2 Ovsynch program durations [5 d: GnRH (GnRH-1)–5 d–PGF_2α–24 h–PGF_2α–32 h–GnRH (GnRH-2)–16 h–timed AI; 7 d: GnRH-1–7 d–PGF_2α–56 h–GnRH-2–16 h–timed AI], and (3) 2 PGF_2α dose frequency treatments (2 × 25 mg) 24 h apart versus 1 dose (1 × 50 mg) of PGF_2α administered 72 h before timed AI. The presynchronization treatments of PG-3-G and Double Ovsynch had no effect on the proportion of cows with luteal function at the onset of the Ovsynch treatments (87.9 vs. 86.2%). Although ovulatory responses were similar after GnRH-1 (>60%), Double Ovsynch cows tended to have greater ovulatory responses than PG-3-G after GnRH-2 (95.3 vs. 90.6%). The 2 × 25-mg doses of PGF_2α and the 1 × 50-mg dose induced luteolysis in both Ovsynch treatment durations, but the 1 × 50-mg dose was less effective in the 5-d program. More pregnancy per AI (P/AI; 49.2%) tended to occur in the PG-3-G cows in the 7-d program compared with the other treatment combinations (range: 32.4–37.4%; Ovsynch × presynch interaction). In addition, an Ovsynch × PGF_2α dose frequency interaction resulted in cows receiving the 1 × 50-mg dose in the 7-d program having the greatest P/AI (46.1%) and cows receiving the 1 × 50-mg dose in the 5-d program having the least P/AI (30.6%). We conclude that complete luteolysis was less effective in the 5-d program when the 1 × 50-mg dose was applied, but both PGF_2α dose frequencies (1 × 50 mg and 2 × 25 mg 24 h apart) effectively induced complete luteolysis in the 7-d program. Treatments producing complete luteolysis tended to be related to subsequent pregnancy outcomes.     

Ovarian traits after gonadotropin-releasing hormone-induced ovulation and subsequent delay of induced luteolysis in an Ovsynch protocol

Our objective was to determine whether delaying the PGF_2α injection by 24 or 48 h after the first GnRH injection in an Ovsynch protocol (from a standard 7 d) altered ovarian characteristics in lactating dairy cows. Beginning 9 d after removal of a progesterone-releasing controlled internal drug release (CIDR) insert and injection of PGF_2α (d 6.4 of the estrous cycle), 36 Holsteins (average body weight = 707 ± 12 kg and body condition score = 2.3 ± 0.1) were administered 100 μg of GnRH (81 ± 2 d in milk) and assigned randomly to receive a treatment injection of PGF_2α 7, 8, or 9 d later. Timed artificial insemination was performed at 48 h after PGF_2α at which time a second injection of GnRH was administered. Ovarian structures were mapped by ultrasonography on d 0 (first GnRH injection); on d 2 to determine responses to the first GnRH injection; at PGF_2α injection; and daily thereafter through 72 h after PGF_2α to monitor ovulation of preovulatory follicles. Blood was collected on d 0, 2, at PGF_2α injection, and at 24 and 48 h after PGF_2α to monitor serum changes in estradiol-17β (E2-17β) and progesterone (P4). Based on serum P4 and ovarian exams, 2 cows were eliminated because of anestrus and their failure to ovulate a follicle in response to the first GnRH injection. Two other cows in which luteolysis failed to occur after PGF_2α treatment also were eliminated. Final numbers of cows per treatment were: 7 d (n = 13), 8 d (n = 9), and 9 d (n = 10). Twenty-nine of 32 cows ovulated (90.6%) in response to the first GnRH injection. Of those cows not ovulating in response to the first GnRH injection, 2 had 1 original corpus luteum and 1 had 2 original corpora lutea. Despite a 24- or 48-h delay between first GnRH and PGF_2α injections, the diameter (mm) and volume (mm³) of the ovulatory follicle did not differ among treatments: 14.3 ± 0.6 and 1,526 ± 62 at 7 d; 14.1 ± 0.8 and 1,479 ± 97 at 8 d; and 15.3 ± 0.9 and 1,490 ± 69 at 9 d. In all 32 cows, at least 1 follicle ovulated after treatment, but ovulation rates did not differ: 1.2 ± 0.1, 1.1 ± 0.1, and 1.3 ± 0.2, respectively, for the 7-, 8-, and 9-d treatments. Serum concentrations of E2-17β did not differ among treatments. Four cows in the 7-d treatment were inseminated 24 h late and were excluded before assessing conception rates, which were 5/9 (55.6%), 5/9 (55.6%), and 1/10 (10%), respectively. We conclude that delaying PGF_2α injection by 24 h had no effect on outcomes.     

Concentration of progesterone during the development of the ovulatory follicle: II. Ovarian and uterine responses

Two experiments evaluated the influence of altering the concentrations of progesterone during the development of the ovulatory follicle on the composition of the follicular fluid, circulating LH and PGF_2α metabolite (PGFM), and expression of endometrial progesterone receptor and estrogen receptor-α. In both experiments, the estrous cycles were presynchronized (GnRH and progesterone insert followed by insert removal and PGF_2α 7 d later, and GnRH after 48 h) and cows were then enrolled in 1 of 2 treatments 7 d later (study d −16): high progesterone (HP) or low progesterone (LP). In experiment 1 (n = 19), cows had their estrous cycle synchronized starting on study d −9 (GnRH and progesterone insert on d −9, and insert removal and PGF_2α on d −2). In experiment 2 (n = 25), cows were submitted to the same synchronization protocol as in experiment 1, but had ovulation induced with GnRH on study d 0. In experiment 1, plasma was sampled on d −4 and analyzed for concentrations of LH; the dominant follicle was aspirated on d 0 and the fluid analyzed for concentrations of progesterone, estradiol, and free and total IGF-1. In experiment 2, follicular development and concentrations of progesterone and estradiol in plasma were evaluated until study d 16. Uterine biopsies were collected on d 12 and 16 for progesterone receptor and estrogen receptor-α protein abundance. An estradiol/oxytocin challenge for PGFM measurements in plasma was performed on d 16. In experiments 1 and 2, LP cows had lower plasma concentrations of progesterone and greater concentrations of estradiol, and had larger ovulatory follicle diameter (20.4 vs. 17.2 mm) at the end of the synchronization protocol than HP cows. Concentration of LH tended to be greater for LP than HP cows (0.98 vs. 0.84 ng/mL). The dominant follicle of LP cows had greater concentration of estradiol (387.5 vs. 330.9 ng/mL) and a lower concentration of total IGF-1 (40.9 vs. 51.7 ng/mL) than that of HP cows. In experiment 2, estradiol and progesterone concentrations did not differ between treatments from d 0 to 16; however, the proportion of cows with a short luteal phase tended to increase in LP than HP (25 vs. 0%). Concentrations of PGFM were greater for LP than HP. Uterine biopsies had a greater abundance of progesterone receptor, and tended to have less estrogen receptor-α abundance on d 12 compared with d 16. An interaction between treatment and day of collection was detected for estrogen receptor-α because of an earlier increase in protein abundance on d 12. Reduced concentrations of progesterone during the development of the ovulatory follicle altered follicular dynamics and follicular fluid composition, increased basal LH concentrations, and prematurely increased estrogen receptor-α abundance and exacerbated PGF_2α release in the subsequent estrous cycle.     

Vascular and morphological features of the corpus luteum 12 to 20 days after timed artificial insemination in dairy cattle

Our objective was to retrospectively compare pregnant versus nonpregnant cattle in terms of vascular and morphometric changes in corpora lutea between d 12 and 20 following timed artificial insemination (TAI). Crossbred (Gir × Holstein) lactating dairy cows (n = 136) and heifers (n = 111) were bred after synchronizing ovulations using an estradiol plus progesterone (P4)-based protocol. Corpus luteum (CL) characteristics (area, echotexture, blood flow) were recorded at 48-h intervals from d 12 to 20 following TAI using an ultrasound equipped with color Doppler. Blood samples were collected to determine CL function (plasma P4). Pregnancy diagnosis was performed at d 30. Quantitative assessment of colored pixels within the CL was performed using ImageJ software (National Institutes of Health, Bethesda, MD) and echotexture was quantified using custom software. Continuous variables such as luteal tissue area (LTA), CL blood flow (CLBF), adjusted CLBF (ratio LTA:CLBF), mean pixel value (MPV), pixel heterogeneity (HETER), and plasma P4 were analyzed retrospectively as repeated measures (d 12 to 20) in pregnant versus nonpregnant females using PROC MIXED (SAS Institute Inc., Cary, NC). Main effects were pregnancy status, day of cycle, and their interaction. Further analyses used only data from d 16, because this was the earliest time point of deviation between CLBF of pregnant and nonpregnant animals. We created quartiles for each variable and calculated the risk of pregnancy within quartile. Differences were determined using the chi-squared test. Plasma P4 was significantly higher in prospective pregnant versus nonpregnant cattle on d 18 and 20, whereas LTA differed only on d 20. On d 16, CLBF and adjusted CLBF diverged between pregnant and nonpregnant, followed by a progressive reduction in the latter until d 20. Mean pixel value was not affected by pregnancy status, but HETER was lower on d 20 in pregnant than in nonpregnant cattle. Likelihood of pregnancy increased from quartile (Q)1 (lowest values) to Q4 (highest) of CLBF (Q4 vs. Q1, odds ratio = 32.8, 95% confidence interval: 9.6 to 112.1) and adjusted CLBF [Q4 vs. Q1, odds ratio = 25.4, 95% confidence interval: 8.1 to 80.4), whereas a lower risk of pregnancy was observed only for animals within Q1 of plasma P4 [Q4 vs. Q1, odds ratio = 3.1, 95% confidence interval: 1.3 to 7.2). Day 16 quartiles of LTA, MPV, and HETER did not affect odds of pregnancy. In conclusion, we identified distinct CLBF patterns as early as 16 d after TAI and confirmed that CL function is lost by a reduction in blood flow, which precedes physical regression.     

Alternative programs to presynchronize estrous cycles in dairy cattle before a timed artificial insemination program

The objective was to test potential presynchronization programs applied to cows before a timed artificial insemination (TAI) program to increase the percentage of cows ovulating in response to both GnRH injections of a TAI program and having a functional corpus luteum before the first GnRH injection of the TAI program. At calving, cows were blocked by lactation (1 vs. 2+) and assigned randomly to receive 1 of 5 presynchronization treatments. Two variants of the standard Presynch program were tested in which 2 injections of PGF_2α were administered 14 d apart with either 14 d (Pre14; n = 122), 12 d (Pre12; n = 123), or 10 d (Pre10; n = 151) intervening before a TAI program was initiated. Two other presynchronization programs consisted of administering a progesterone-releasing controlled internal drug release (CIDR) insert for 7 d plus PGF_2α administration at insert removal. Insert removal occurred either 10 d (CIDR10; n = 157) or 3 d (CIDR3; n = 117) before a TAI program was initiated. The TAI program was a standard Cosynch program [injection of GnRH 7 d before (GnRH-1) and 72 h after (GnRH-2) PGF_2α with TAI administered 72 h after PGF_2α). Cosynch served as the control (n = 157), and cows were assumed to be starting this program at random stages of the estrous cycle. From a subset of cows per treatment (ranging from 49 to 51 cows each), blood samples were collected from coccygeal vessels by using evacuated tubes at d −28, −14, 0 (onset of TAI program), 7, 9, 14, and 21. Ovarian scans were conducted on d 0, 7, 9, 14, and 21 by transrectal ultrasonography. Diameters of follicles and corpus luteum were measured at each exam, and ovulation was determined on d 7 (response to GnRH-1 on d 0) and d 14 (response to GnRH-2 on d 10). Ovulatory incidence after GnRH-1 (47.1 to 67.3%) and GnRH-2 (78 to 90.2%) varied but did not differ among treatments. Before GnRH-1, progesterone concentrations were less in the CIDR3 treatment than in all other treatments. Before GnRH-2, progesterone was greater in the CIDR3 treatment than in all other treatments. Luteal regression and synchronization rate (successful luteolysis and ovulation after GnRH-2) did not differ among treatments. Pregnancy rate per AI at 32 and 60 d post TAI was less in CIDR3 cows than in cows in all other treatments. None of the Presynch treatments improved key responses (ovulation, luteolysis, and synchronization rate) known to improve fertility compared with a standard Cosynch program without presynchronization.     

Luteolytic effects of cloprostenol sodium in lactating dairy cows treated with G6G/Ovsynch

The probability of a pregnancy decreases substantially in lactating dairy cows treated with Ovsynch if luteolysis is delayed or incomplete. Two PGF_2α products are currently approved in the United States for luteolysis in lactating dairy cattle, dinoprost tromethamine and cloprostenol sodium. Cloprostenol has a longer half-life compared with dinoprost, is more resistant to endogenous metabolism, and is maintained in circulation longer. We hypothesized that cloprostenol could reduce the time to complete luteolysis compared with dinoprost because of differences in half-life. Lactating dairy cows received the same presynchronization strategy (G6G; 25 mg of PGF_2α - 2 d - 100 μg of GnRH - 6 d - 100 μg of GnRH - 7 d - final PGF_2α treatment). At the time of the final PGF_2α, cows (n = 35) were randomly assigned to receive either 500 μg of cloprostenol or 25 mg of dinoprost. Blood samples were collected daily before and serially after PGF_2α treatment to analyze circulating concentrations of progesterone (P₄) and estradiol (E₂). Ultrasound examinations of ovaries were performed to measure sizes of follicles and corpora lutea (CL) and determine time of ovulation. Considering only cows with complete luteolysis, mean circulating P₄ was lower for cows given cloprostenol than for those given dinoprost between 0 and 12 h postinjection, but not at 24, 36, or 48 h. A rapid decrease in P₄ was observed 1 h after PGF_2α (6.54 ± 0.27 to 3.77 ± 0.22 ng/mL) followed by a complete rebound 1 h later (3.77 ± 0.22 to 5.07 ± 0.31 ng/mL) followed by a steady decline in both treatment groups. Serum concentrations of E₂ were greater at 48 h posttreatment in cloprostenol-treated cows (2.74 ± 0.15 pg/mL) than in dinoprost-treated cows (2.37 ± 0.19 pg/mL). Cows that did not have complete luteolysis did not ovulate (0/7) during the 6-d period following treatment. Time to complete luteolysis and ovulation was 29.1 ± 1.1 versus 29.4 ± 1.7 and 101 versus 103 h posttreatment in cloprostenol compared with dinoprost. A negative relationship was observed between P₄ at 12 h posttreatment and concentrations of E₂ 48 h posttreatment (b = −0.6905; R² = 0.23). In summary, cows treated with cloprostenol had lower concentrations of P₄ for the first 12 h following treatment and subsequently greater concentrations of E₂ compared with dinoprost, although no differences were observed in these 2 PGF_2α analogs for time to complete luteolysis or time to ovulation.     

Luteolysis,progesterone, and pregnancy per insemination after modifying the standard 7-day Ovsynch program in Holstein-Friesian and Holstein cows

Two experiments were conducted with Holstein-Friesian cows in the Republic of North Macedonia and with Holstein cows in Kansas. We hypothesized that 1 dose of PGF_2α administered on d 8 (Ov-8×1) instead of d 7 (Ov-7×1) in an Ovsynch program [GnRH-1 (d 0)–7 d–PGF_2α–56 h–GnRH-2–16 h–timed artificial insemination (AI)] would increase the proportion of cows with complete luteolysis compared with controls receiving a single dose on d 7. Cows were treated with Ov-7×1 or with Ov-8×1 in experiment 1 (n = 347), using only a single dose of PGF_2α. In experiment 2 (n = 452), a third treatment was added (Ov-7×2), in which a second dose of PGF_2α was administered on d 8. Progesterone was measured in blood samples collected before the first or only PGF_2α administration and 72 h later before insemination. Complete luteolysis was defined as having occurred when progesterone was ≥1 ng/mL before PGF_2α and ≤0.3 ng/mL 72 h later (time of AI). Follicles and luteal structures were mapped before GnRH-1 and PGF_2α administrations. The results of experiment 1 demonstrated a greater percentage of multiparous cows in OV-8×1 having complete luteal regression compared with multiparous Ov-7×1 cows, whereas treatments were equally effective in primiparous cows, as reflected in the concentrations of progesterone before AI. Furthermore, pregnancy per AI did not differ between treatments. Results in experiment 2 revealed that 99.3% of cows in the Ov-7×2 treatment receiving the second dose of PGF_2α had complete luteolysis, regardless of parity, compared with significantly fewer cows in the Ov-7×1 and Ov-8×1 treatments (91.2 and 90.6%, respectively). Neither concentrations of progesterone, which averaged <0.4 ng/mL at AI, nor pregnancy per AI differed among the 3 treatments. In both experiments, when status of luteal function before PGF_2α treatment was examined [cows with no corpus luteum (CL) before GnRH-1 but which had formed a new CL in response to ovulation after GnRH-1; cows with an older CL (the same CL that was detected before GnRH-1); or cows with both a new and an older CL], treatments did not differ in causing complete luteolysis. Furthermore, complete luteolysis in experiment 2 did not differ regardless of whether cows had 1, 2, or 3 or more CL before PGF_2α administration. Pregnancy per AI did not differ among treatments, indicating that any of the 3 treatments might produce similar pregnancy outcomes with the flexibility of applying either of the 7- or the 8-d treatments.